Search research articles
Contact Us
Filters
Showing results (171-180 of 499) with videos related to
Page
of 50
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2020
[<sup>18</sup>F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [<sup>68</sup>Ga]Ga-DOTATATE in neuroendocrine tumour patients
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2019
Al<sup>18</sup>F-NOTA-octreotide: first comparison with <sup>68</sup>Ga-DOTATATE in a neuroendocrine tumour patient
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
The New England Journal of Medicine
|
July 23, 2004
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
David Cunningham, Yves Humblet, Salvatore Siena, et al.
Investigational New Drugs
|
September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Pancreas
|
December 6, 2014
Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial
Catherine Lombard-Bohas, James C Yao, Timothy Hobday, et al.
Endocrine-Related Cancer
|
September 17, 2015
Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
Jonathan R Strosberg, James C Yao, Emilio Bajetta, et al.
Journal of Geriatric Oncology
|
November 15, 2017
Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS)
Lore Decoster, Cindy Kenis, Benedicte Naessens, et al.
Frontiers in Oncology
|
January 31, 2025
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
Julien Taieb, Marwan Fakih, Gabor Liposits, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 24, 2022
[<sup>68</sup>Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [<sup>177</sup>Lu]Lu-DOTATATE PRRT
Elin Pauwels, Jeroen Dekervel, Chris Verslype, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 2010
A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma
Hannah van Malenstein, Olivier Gevaert, Louis Libbrecht, et al.
Page
of 50
Search research articles
Search
Showing results (171-180 of 499) with videos related to
Sort By:
Page
of 50
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2020
[<sup>18</sup>F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [<sup>68</sup>Ga]Ga-DOTATATE in neuroendocrine tumour patients
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2019
Al<sup>18</sup>F-NOTA-octreotide: first comparison with <sup>68</sup>Ga-DOTATATE in a neuroendocrine tumour patient
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
The New England Journal of Medicine
|
July 23, 2004
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
David Cunningham, Yves Humblet, Salvatore Siena, et al.
Investigational New Drugs
|
September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Pancreas
|
December 6, 2014
Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial
Catherine Lombard-Bohas, James C Yao, Timothy Hobday, et al.
Endocrine-Related Cancer
|
September 17, 2015
Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
Jonathan R Strosberg, James C Yao, Emilio Bajetta, et al.
Journal of Geriatric Oncology
|
November 15, 2017
Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS)
Lore Decoster, Cindy Kenis, Benedicte Naessens, et al.
Frontiers in Oncology
|
January 31, 2025
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer
Julien Taieb, Marwan Fakih, Gabor Liposits, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 24, 2022
[<sup>68</sup>Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [<sup>177</sup>Lu]Lu-DOTATATE PRRT
Elin Pauwels, Jeroen Dekervel, Chris Verslype, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 2010
A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma
Hannah van Malenstein, Olivier Gevaert, Louis Libbrecht, et al.
Page
of 50